Oct 16, 2017 8:27 am EDT Abeona Announces $13.85M Grant from Leading Sanfilippo Syndrome Foundations for Clinical Development of MPS III Gene Therapies
Oct 11, 2017 8:19 am EDT Abeona Therapeutics Enrolls First Two Patients in Pivotal Expansion of Phase 1/2 Clinical Trial in MPS IIIA
Oct 6, 2017 8:25 am EDT Abeona Announces Top-Line One Year Data from ABO-102 MPS IIIA Trial at ARM’s Cell & Gene Meeting on the Mesa
Oct 4, 2017 8:45 am EDT Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio
Sep 28, 2017 8:32 am EDT Abeona Therapeutics and Brammer Bio Announce Collaboration for Commercial Translation of ABO-102
Aug 29, 2017 9:05 am EDT Abeona Therapeutics Receives FDA Breakthrough Therapy Designation for EB-101 Autologous Cell Therapy in Epidermolysis Bullosa
Aug 15, 2017 8:25 am EDT Abeona Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights
Jul 25, 2017 8:05 am EDT Abeona Therapeutics Announces Appointment of Juan Ruiz as Chief Medical Officer
